TW200740797A - Crystalline forms of 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarbonitrile and methods of preparing the same - Google Patents

Crystalline forms of 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarbonitrile and methods of preparing the same

Info

Publication number
TW200740797A
TW200740797A TW095123896A TW95123896A TW200740797A TW 200740797 A TW200740797 A TW 200740797A TW 095123896 A TW095123896 A TW 095123896A TW 95123896 A TW95123896 A TW 95123896A TW 200740797 A TW200740797 A TW 200740797A
Authority
TW
Taiwan
Prior art keywords
methoxyphenyl
propoxy
dichloro
methoxy
amino
Prior art date
Application number
TW095123896A
Other languages
English (en)
Inventor
Marc Sadler Tesconi
Gregg Feigelson
Henry Strong
Hong Wen
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37103295&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW200740797(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of TW200740797A publication Critical patent/TW200740797A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
TW095123896A 2005-07-01 2006-06-30 Crystalline forms of 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarbonitrile and methods of preparing the same TW200740797A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69638105P 2005-07-01 2005-07-01

Publications (1)

Publication Number Publication Date
TW200740797A true TW200740797A (en) 2007-11-01

Family

ID=37103295

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095123896A TW200740797A (en) 2005-07-01 2006-06-30 Crystalline forms of 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarbonitrile and methods of preparing the same

Country Status (25)

Country Link
US (2) US7767678B2 (zh)
EP (1) EP1902029B2 (zh)
JP (1) JP2009500332A (zh)
KR (1) KR20080028386A (zh)
CN (1) CN101248047A (zh)
AR (1) AR054505A1 (zh)
AU (1) AU2006266045A1 (zh)
BR (1) BRPI0613574A2 (zh)
CA (1) CA2613053C (zh)
CR (1) CR9596A (zh)
DK (1) DK1902029T4 (zh)
EC (1) ECSP078063A (zh)
ES (1) ES2449197T5 (zh)
GT (1) GT200600282A (zh)
HK (1) HK1114614A1 (zh)
IL (1) IL188483A0 (zh)
MX (1) MX2008000384A (zh)
NO (1) NO20080051L (zh)
PA (1) PA8685101A1 (zh)
PE (1) PE20070190A1 (zh)
PL (1) PL1902029T5 (zh)
PT (1) PT1902029E (zh)
RU (1) RU2007148072A (zh)
TW (1) TW200740797A (zh)
WO (1) WO2007005462A1 (zh)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102470109A (zh) * 2009-07-02 2012-05-23 惠氏有限责任公司 3-氰基喹啉片剂制剂及其应用
WO2013187967A1 (en) 2012-06-15 2013-12-19 Institute For Cancer Research D/B/A The Research Institute Of Fox Case Cancer Center ("Fox Chase Cancer Center") Sensitization of cancer cells to dna damage by inhibiting kinases essential for dna damage checkpoint control
CN104447541A (zh) * 2013-09-16 2015-03-25 天津市汉康医药生物技术有限公司 博舒替尼化合物
WO2015123758A1 (en) * 2014-02-20 2015-08-27 Apotex Inc. Bosutinib forms and preparation methods thereof
WO2015149727A1 (en) 2014-04-02 2015-10-08 Zentiva, K.S. Novel solid phases of 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1 -piperazinyl)propoxy]-3-quinolinecarbonitrile
CN105384686B (zh) * 2014-09-04 2019-07-26 连云港润众制药有限公司 一种博舒替尼结晶方法
WO2016034150A1 (zh) * 2014-09-04 2016-03-10 正大天晴药业集团股份有限公司 博舒替尼及其结晶的制备方法
WO2017029584A1 (en) * 2015-08-19 2017-02-23 Sun Pharmaceutical Industries Limited Amorphous form of bosutinib
WO2017134679A1 (en) * 2016-02-03 2017-08-10 Msn Laboratories Private Limited Novel crystalline polymorphs of 4-[(2.4-dichioro-5-methoxvphenvl)aniinol- 6-methoxv-7-13-(4-methyl-l-piperazinvl)propoxvl-3-quinolinecarbonitrile and process for preparation thereof
WO2017145089A1 (en) * 2016-02-23 2017-08-31 Sun Pharmaceutical Industries Limited Crystalline form x of bosutinib
CN105646345A (zh) * 2016-03-16 2016-06-08 浙江海正药业股份有限公司 博舒替尼的新晶型及其制备方法
CN106187886B (zh) * 2016-07-06 2019-04-16 山东创新药物研发有限公司 一种制备高纯度伯舒替尼一水合物的方法
JOP20190144A1 (ar) 2016-12-16 2019-06-16 Janssen Pharmaceutica Nv إيميدازو بيرولو بيريدين كمثبطات لعائلة jak الخاصة بإنزيمات الكيناز
CN110317168A (zh) * 2018-03-30 2019-10-11 正大天晴药业集团股份有限公司 一种博舒替尼的纯化方法
TW202016110A (zh) 2018-06-15 2020-05-01 比利時商健生藥品公司 Ｊａｋ激酶家族之小分子抑制劑
WO2020209843A1 (en) 2019-04-09 2020-10-15 Massachusetts Institute Of Technology A micro physiological model for neuronal and muscular diseases and disorders
CN112321505B (zh) * 2019-10-25 2022-08-23 杭州中美华东制药有限公司 一种伯舒替尼晶型及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6002008A (en) * 1997-04-03 1999-12-14 American Cyanamid Company Substituted 3-cyano quinolines
US6432979B1 (en) * 1999-08-12 2002-08-13 American Cyanamid Company Method of treating or inhibiting colonic polyps and colorectal cancer
UA77200C2 (en) * 2001-08-07 2006-11-15 Wyeth Corp Antineoplastic combination of cci-779 and bkb-569
TWI275390B (en) * 2002-04-30 2007-03-11 Wyeth Corp Process for the preparation of 7-substituted-3- quinolinecarbonitriles
TW200423938A (en) * 2003-02-21 2004-11-16 Wyeth Corp 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-alkoxy-3-quinolinecarbonitriles for the treatment of ischemic injury
MXPA06001590A (es) * 2003-08-19 2006-05-19 Wyeth Corp Proceso para la preparacion de 4-amino-3-quinolincarbonitrilos.
WO2005065074A2 (en) * 2003-09-09 2005-07-21 Temple University Of The Commonwealth System Of Higher Education Protection of tissues and cells from cytotoxic effects of ionizing radiation by abl inhibitors
WO2005047259A1 (en) * 2003-11-06 2005-05-26 Wyeth 4-anilino-3-quinolinecarbonitriles for the treatment of chronic myelogenous leukemia (cml)
US7910211B2 (en) * 2005-06-20 2011-03-22 E.I. Du Pont De Nemours And Company Process for the production of multi-layer coatings
BRPI0611977A2 (pt) 2005-06-24 2010-10-13 Wyeth Corp uso de um composto
US8520232B2 (en) * 2006-03-31 2013-08-27 Konica Minolta Laboratory U.S.A., Inc. Print job analyzing method and apparatus with print device recommendation functions

Also Published As

Publication number Publication date
CR9596A (es) 2008-03-06
GT200600282A (es) 2007-02-14
US7767678B2 (en) 2010-08-03
DK1902029T4 (da) 2022-02-28
NO20080051L (no) 2008-01-29
US20100324066A1 (en) 2010-12-23
US8445496B2 (en) 2013-05-21
WO2007005462A1 (en) 2007-01-11
ES2449197T3 (es) 2014-03-18
EP1902029A1 (en) 2008-03-26
CA2613053C (en) 2015-11-24
AR054505A1 (es) 2007-06-27
HK1114614A1 (zh) 2008-11-07
CA2613053A1 (en) 2007-01-11
MX2008000384A (es) 2008-03-07
BRPI0613574A2 (pt) 2016-11-16
EP1902029B2 (en) 2022-02-16
ES2449197T5 (es) 2022-04-28
PT1902029E (pt) 2014-03-05
KR20080028386A (ko) 2008-03-31
DK1902029T3 (en) 2014-02-17
AU2006266045A1 (en) 2007-01-11
EP1902029B1 (en) 2014-01-08
PL1902029T5 (pl) 2022-08-29
US20070015767A1 (en) 2007-01-18
PA8685101A1 (es) 2007-01-17
PL1902029T3 (pl) 2014-08-29
IL188483A0 (en) 2008-04-13
PE20070190A1 (es) 2007-03-20
RU2007148072A (ru) 2009-08-10
ECSP078063A (es) 2008-01-23
JP2009500332A (ja) 2009-01-08
CN101248047A (zh) 2008-08-20

Similar Documents

Publication Publication Date Title
TW200740797A (en) Crystalline forms of 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarbonitrile and methods of preparing the same
IL185242A0 (en) 3,4-substituted pyrrolidine derivatives for the treatment of hypertension
NO20076066L (no) Oksadiazolderivater som DGAT-inhibitorer
AP1997A (en) 3-(3,5-dioxo-4,5-dihydro-3H-(1,2,4)triazin-2-YL)-benzamide derivatives as P2X7-inhibitors for the treatment of inflammatory diseases
NO20082481L (no) Nye 2-aminoheterosykluser som er nyttige ved behandling av ABETA-relaterte patologier
WO2008076046A8 (en) Novel 2-amino-5, 5-diaryl-imidazol-4-ones
WO2006041405A1 (en) Substituted amino-pyrimidones and uses thereof
WO2008049105A3 (en) Sulfamoyl-containing derivatives and uses thereof
AU2003281978A1 (en) 2,5-diketopiperazines for the treatment of obesity
IL194947A0 (en) Aryl-4-ethynyl-isoxazole derivatives
TW200637822A (en) Process for the preparation of a 2-pyridylethylcarboxamide derivative
NO20060020L (no) 3-fluorpiperidiner som NMDA/NR2B-antagonister
TW200633981A (en) Process for the preparation of a 2-ethylaminopyridine derivative
NO20054070D0 (no) 4-[(2,4-diklor-5-metoksyfenyl)amino]-6-alkoksy-3-kinol inkarbonitriler for behandling av isjemisk skade.
MX2010002938A (es) Derivados de (3-hidroxi-4-amino-butan-2-il)-3-(2-tiazol-2-il-pirro lidin-1-carbonil)benzamida y compuestos relacionados como inhibidores de beta-secretasa para tratar enfermedad de alzheimer.
HK1114840A1 (en) Malonamide derivatives as inhibitors of gamma-secretase for the treatment of alzheimer's disease
IL186777A0 (en) (3,4-dihydro-quinazolin-2-yl) - (2-aryloxy-ethyl) - amines having an activity on the 5 - ht receptor
WO2008104847A3 (en) Processes for the preparation of pramipexole and salts thereof
EP1951709A4 (en) IMIDAZOLIDINONE COMPOUNDS USEFUL AS BETA-SECRETASE INHIBITORS IN THE TREATMENT OF ALZHEIMER'S DISEASE
SI2176229T1 (sl) Nove kristalne oblike 3-(difluormetil)-1-metil-n-(3',4',5'-trifluor(1,1'-bifenil)-2-il)-1h- pirazol-4-karboksamida
IL186676A0 (en) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility
ZA200709096B (en) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility
PL1631296T3 (pl) Pochodne amidu kwasu 2,3,4,5,-tetrahydrobenzo[f][1,4]oksazepino-5-karboksylowego jako inhibitory gamma-sekretazy do leczenia choroby Alzheimera
ZA200800138B (en) Process for the preparation of crystalline perindopril
CY1114781T1 (el) Κρυσταλλικες μορφες 4-[(2,4-διχλωρο-5-μεθοξυφαινυλ)αμινο]-6-μεθοξυ-7-[3-(4-μεθυλ-1-πιπεραζινυλ)προποξυ]-3-κινολινοκαρβονιτριλιου και μεθοδοι παρασκευης αυτων